FDA Inspection 1306606 — DiaPharma Group Inc
The FDA completed an inspection of DiaPharma Group Inc on February 25, 2026 in West Chester, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 25, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- West Chester, OH (United States)